[SYRE] YoY Annual Result on 31-Dec-2020 [#FY]

Stock
[SYRE] Spyre Therapeutics, Inc.
Announcement Date
30-Dec-2020
Financial Year
2020
Quarter
31-Dec-2020 [#FY]
Profit Trend
YoY- -3.37%
Quarter Report
SYRE's Result
SYRE's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 886 2,329 18,739 0 0 3,888 5,205 -25.54%
PBT -338,816 -83,951 -65,660 -80,893 -78,254 -44,348 -27,236 52.19%
Tax -26 -136 141 -593 0 0 0 -
NP -338,790 -83,815 -65,801 -80,893 -78,254 -44,348 -27,236 52.18%
Tax Rate - - - - - - - -
Total Cost 339,676 86,144 84,540 80,893 78,254 48,236 32,441 47.88%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -38,238.15 -3,598.75 -351.14 0.00 0.00 -1,140.64 -523.27 104.40%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -49.12 -24.86 -25.02 -37.89 -61.23 -53.25 -45.01 1.46%
EPS Diluted -49.12 -24.86 -25.02 -37.89 -61.23 -53.25 -45.01 1.46%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.